Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XOMA. Bull or Bear? -- Ignore unavailable to you. Want to Upgrade?

To: Ellen M. Martin who wrote (7917)	12/2/1998 5:41:00 PM
From: Robert K.	Read Replies (1) \| Respond to of 17367

Ahhhhhh. Those changes are oh so subtle. Subtle but significant according to my thinking. Of course we really dont know how 1999 will pan out , but it sure is shaping up to be a year of changes. All IMO.

To: Ellen M. Martin who wrote (7917)	2/2/1999 2:13:00 PM
From: aknahow	Read Replies (3) \| Respond to of 17367

Ellen, if the trial is complete, and XOMA had announced it, do you think XOMA would still be going down today? I sort of doubt it. Think it probably would have gone up. I want to believe XOMA will tell all shareholders, at the same time when the trial does conclude. But given what has become standard practice I can't. When the information is unblinded, it is imperative that shareholders be told the mortality as well as number of accruals in each arm. XOMA does not need to go into the statistical significance of the results if it feels it should not. The terrible thing is that I feel XOMA will have some esoteric reason for not doing any of the above. Guess I have to see one more card but I also am getting close to throwing in my hand.